Inogen (NASDAQ:INGN – Get Free Report) and QT Imaging (NASDAQ:QTI – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.
Risk & Volatility
Inogen has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of 0.02, indicating that its share price is 98% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Inogen and QT Imaging, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Inogen | 1 | 0 | 0 | 1 | 2.50 |
| QT Imaging | 1 | 1 | 2 | 0 | 2.25 |
QT Imaging has a consensus price target of $8.00, suggesting a potential upside of 238.98%. Given QT Imaging’s higher probable upside, analysts clearly believe QT Imaging is more favorable than Inogen.
Insider and Institutional Ownership
89.9% of Inogen shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 2.5% of Inogen shares are owned by insiders. Comparatively, 25.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Inogen and QT Imaging”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Inogen | $348.67 million | 0.54 | -$22.75 million | ($0.90) | -7.82 |
| QT Imaging | $18.92 million | 1.72 | -$21.08 million | ($1.57) | -1.50 |
QT Imaging has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Inogen and QT Imaging’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Inogen | -6.94% | -13.17% | -8.36% |
| QT Imaging | -77.25% | -1,202.69% | -46.76% |
Summary
Inogen beats QT Imaging on 9 of the 14 factors compared between the two stocks.
About Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.
